UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 142

Sortiert nach

Weakly supervised 3D deep learning for breast cancer classification and localization of the lesions in MR images

Journal of magnetic resonance imaging, 2019-10, Vol.50 (4), p.1144-1151

2019

Volltextzugriff (PDF)

Endocrine therapy combined with targeted therapy in hormone receptor-positive metastatic breast cancer

Chinese medical journal, 2020-10, Vol.133 (19), p.2338-2345

2020

Volltextzugriff (PDF)

Profile and outcome of receptor conversion in breast cancer metastases: a nation‐wide multicenter epidemiological study

International journal of cancer, 2021-02, Vol.148 (3), p.692-701

2021

Volltextzugriff (PDF)

Auricular acupressure for constipation in adults: a systematic review and meta-analysis

Frontiers in physiology, 2023-10, Vol.14, p.1257660-1257660

2023

Volltextzugriff (PDF)

Molecular subtypes predict the preferential site of distant metastasis in advanced breast cancer: a nationwide retrospective study

Frontiers in oncology, 2023-01, Vol.13, p.978985-978985

2023

Volltextzugriff (PDF)

Circulating-free DNA Mutation Associated with Response of Targeted Therapy in Human Epidermal Growth Factor Receptor 2-positive Metastatic Breast Cancer

Chinese medical journal, 2017-03, Vol.130 (5), p.522-529

2017

Volltextzugriff (PDF)

PTEN mutation, methylation and expression in breast cancer patients

Oncology letters, 2013-07, Vol.6 (1), p.161-168

2013

Volltextzugriff (PDF)

P2X7 receptor is essential for ST36-attenuated cardiac fibrosis upon beta-adrenergic insult

Purinergic signalling, 2024-04

2024

Volltextzugriff (PDF)

Receptor conversion in metastatic breast cancer: a prognosticator of survival

Oncotarget, 2016-11, Vol.7 (44), p.71887-71903

2016

Volltextzugriff (PDF)

Predicting Neoadjuvant Chemotherapy in Nonconcentric Shrinkage Pattern of Breast Cancer Using 1H-Magnetic Resonance Spectroscopic Imaging

Journal of computer assisted tomography, 2018-01, Vol.42 (1), p.12-18

2018

Volltextzugriff (PDF)

MONARCH plus: abemaciclib plus endocrine therapy in women with HR+/HER2– advanced breast cancer: the multinational randomized phase III study

Therapeutic advances in medical oncology, 2020, Vol.12, p.1758835920963925-1758835920963925

2020

Volltextzugriff (PDF)

Inhibition of Human Breast Cancer Cell Invasion by siRNA Against Urokinase-Type Plasminogen Activator

Cancer investigation, 2010-07, Vol.28 (7), p.689-697

2010

Volltextzugriff (PDF)

Remarkable response with pembrolizumab plus albumin-bound paclitaxel in 2 cases of HER2-positive metastatic breast cancer who have failed to multi-anti-HER2 targeted therapy

Cancer biology & therapy, 2018-04, Vol.19 (4), p.292-295

2018

Volltextzugriff (PDF)

Gene Expression Profiling for Breast Cancer Prognosis in Chinese Populations

The breast journal, 2011-03, Vol.17 (2), p.172-179

2011

Volltextzugriff (PDF)

Safety and efficacy of first-line bevacizumab combined with taxane therapy in Chinese patients with HER2-negative locally recurrent or metastatic breast cancer： findings from the ATHENA study

Chinese medical journal, 2012-03, Vol.125 (5), p.764-769

2012

Volltextzugriff (PDF)

Use of Breast Magnetic Resonance Imaging and Ultrasonography for Identifying Nonpalpable Axillae Metastases in Newly Diagnosed Breast Cancer Patients

Clinical breast cancer, 2018-02, Vol.18 (1), p.e65-e71

2018

Volltextzugriff (PDF)

Evaluation of treatment response for breast cancer： are we entering the era of ＂biological complete remission

Chinese journal of cancer research, 2012-12, Vol.24 (4), p.403-407

2012

Volltextzugriff (PDF)

Telomerase-specific oncolytic virotherapy for human hepatocellular carcinoma

World journal of gastroenterology : WJG, 2008-02, Vol.14 (8), p.1274-1279

2008

Volltextzugriff (PDF)

A prospective, multicenter, controlled, observational study to evaluate the efficacy of a patient support program in improving patients’ persistence to adjuvant aromatase inhibitor medication for postmenopausal, early stage breast cancer

Breast cancer research and treatment, 2012-07, Vol.134 (1), p.307-313

2012

Volltextzugriff (PDF)

Basic principle and new strategy of endocrine therapy for breast cancer patients

Zhong hua yi xue za zhi, 2012-05, Vol.92 (20), p.1372-1373

Jiang, Ze-fei

2012

Volltextzugriff (PDF)

Switching to anastrozole plus goserelin vs continued tamoxifen for adjuvant therapy of premenopausal early-stage breast cancer: preliminary results from a randomized trial

Cancer management and research, 2019-01, Vol.11, p.299-307

2019

Volltextzugriff (PDF)

Comparisons of Treatment for HER2-Positive Breast Cancer between Chinese and International Practice: A Nationwide Multicenter Epidemiological Study from China

Journal of oncology, 2021, Vol.2021, p.6621722-8

2021

Volltextzugriff (PDF)

Pegylated filgrastim is comparable with filgrastim as support for commonly used chemotherapy regimens: a multicenter, randomized, crossover phase 3 study

Anti-cancer drugs, 2013-07, Vol.24 (6), p.641-647

2013

Volltextzugriff (PDF)

Ki-67 index as a prognostic factor of subsequent lapatinib-based therapy in HER2-positive metastatic breast cancer with resistance to trastuzumab

Cancer biology & therapy, 2014-04, Vol.15 (4), p.365-370

2014

Volltextzugriff (PDF)

1 – 25 von 142

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(119)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(52)
Female
(49)
Science & Technology
(38)
Life Sciences & Biomedicine
(34)
Middle Aged
(34)
Adult
(30)
Breast Neoplasms - Pathology
(27)
Aged
(26)
Breast Neoplasms - Drug Therapy
(25)
Oncology
(22)
Breast Cancer
(20)
乳腺肿瘤
(16)
Breast Neoplasms - Metabolism
(13)
Receptor, Erbb-2 - Metabolism
(12)
Prognosis
(11)
乳腺癌
(11)
Metastasis
(10)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(9)
Male
(9)
Treatment Outcome
(9)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Weakly supervised 3D deep learning for breast cancer classification and localization of the lesions in MR images

Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trial

Endocrine therapy combined with targeted therapy in hormone receptor-positive metastatic breast cancer

Profile and outcome of receptor conversion in breast cancer metastases: a nation‐wide multicenter epidemiological study

Auricular acupressure for constipation in adults: a systematic review and meta-analysis

Molecular subtypes predict the preferential site of distant metastasis in advanced breast cancer: a nationwide retrospective study

Circulating-free DNA Mutation Associated with Response of Targeted Therapy in Human Epidermal Growth Factor Receptor 2-positive Metastatic Breast Cancer

PTEN mutation, methylation and expression in breast cancer patients

P2X7 receptor is essential for ST36-attenuated cardiac fibrosis upon beta-adrenergic insult

Receptor conversion in metastatic breast cancer: a prognosticator of survival

Predicting Neoadjuvant Chemotherapy in Nonconcentric Shrinkage Pattern of Breast Cancer Using 1H-Magnetic Resonance Spectroscopic Imaging

MONARCH plus: abemaciclib plus endocrine therapy in women with HR+/HER2– advanced breast cancer: the multinational randomized phase III study

Inhibition of Human Breast Cancer Cell Invasion by siRNA Against Urokinase-Type Plasminogen Activator

Remarkable response with pembrolizumab plus albumin-bound paclitaxel in 2 cases of HER2-positive metastatic breast cancer who have failed to multi-anti-HER2 targeted therapy

Gene Expression Profiling for Breast Cancer Prognosis in Chinese Populations

Safety and efficacy of first-line bevacizumab combined with taxane therapy in Chinese patients with HER2-negative locally recurrent or metastatic breast cancer： findings from the ATHENA study

Use of Breast Magnetic Resonance Imaging and Ultrasonography for Identifying Nonpalpable Axillae Metastases in Newly Diagnosed Breast Cancer Patients

Evaluation of treatment response for breast cancer： are we entering the era of ＂biological complete remission

Telomerase-specific oncolytic virotherapy for human hepatocellular carcinoma

A prospective, multicenter, controlled, observational study to evaluate the efficacy of a patient support program in improving patients’ persistence to adjuvant aromatase inhibitor medication for postmenopausal, early stage breast cancer

Basic principle and new strategy of endocrine therapy for breast cancer patients

Switching to anastrozole plus goserelin vs continued tamoxifen for adjuvant therapy of premenopausal early-stage breast cancer: preliminary results from a randomized trial

Comparisons of Treatment for HER2-Positive Breast Cancer between Chinese and International Practice: A Nationwide Multicenter Epidemiological Study from China

Pegylated filgrastim is comparable with filgrastim as support for commonly used chemotherapy regimens: a multicenter, randomized, crossover phase 3 study

Ki-67 index as a prognostic factor of subsequent lapatinib-based therapy in HER2-positive metastatic breast cancer with resistance to trastuzumab

Suchergebnisse filtern